Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study

<p><strong>Background</strong> Use of biological or synthetic mesh might improve outcomes of immediate implant-based breast reconstruction—breast reconstruction with implants or expanders at the time of mastectomy—but there is a lack of high-quality evidence to support the safety o...

Повний опис

Бібліографічні деталі
Автори: Potter, S, Conroy, EJ, Cutress, RI, Williamson, PR, Whisker, L, Thrush, S, Skillman, J, Barnes, NLP, Mylvaganam, S, Teasdale, E, Jain, A, Gardiner, M, Blazeby, JM, Holcombe, C
Формат: Journal article
Опубліковано: Elsevier 2019
_version_ 1826284431421210624
author Potter, S
Conroy, EJ
Cutress, RI
Williamson, PR
Whisker, L
Thrush, S
Skillman, J
Barnes, NLP
Mylvaganam, S
Teasdale, E
Jain, A
Gardiner, M
Blazeby, JM
Holcombe, C
author_facet Potter, S
Conroy, EJ
Cutress, RI
Williamson, PR
Whisker, L
Thrush, S
Skillman, J
Barnes, NLP
Mylvaganam, S
Teasdale, E
Jain, A
Gardiner, M
Blazeby, JM
Holcombe, C
author_sort Potter, S
collection OXFORD
description <p><strong>Background</strong> Use of biological or synthetic mesh might improve outcomes of immediate implant-based breast reconstruction—breast reconstruction with implants or expanders at the time of mastectomy—but there is a lack of high-quality evidence to support the safety or effectiveness of the technique. We aimed to establish the short-term safety of immediate implant-based breast reconstruction performed with and without mesh, to inform the feasibility of undertaking a future randomised clinical trial comparing different breast reconstruction techniques.</p> <p><strong>Methods</strong> In this prospective, multicentre cohort study, we consecutively recruited women aged 16 years or older who had any type of immediate implant-based breast reconstruction for malignancy or risk reduction, with any technique, at 81 participating breast and plastic surgical units in the UK. Data about patient demographics and operative, oncological, and complication details were collected before and after surgery. Outcomes of interest were implant loss (defined as unplanned removal of the expander or implant), infection requiring treatment with antibiotics or surgery, unplanned return to theatre, and unplanned re-admission to hospital for complications of reconstructive surgery, up to 3 months after reconstruction and assessed by clinical review or patient self-report. Follow-up is complete. The study is registered with the ISRCTN Registry, number ISRCTN37664281.</p> <p><strong>Findings</strong> Between Feb 1, 2014, and June 30, 2016, 2108 patients had 2655 mastectomies with immediate implant-based breast reconstruction at 81 units across the UK. 1650 (78%) patients had planned single-stage reconstructions (including 12 patients who had a different technique per breast). 1376 (65%) patients had reconstruction with biological (1133 [54%]) or synthetic (243 [12%]) mesh, 181 (9%) had non-mesh submuscular or subfascial implants, 440 (21%) had dermal sling implants, 42 (2%) had pre-pectoral implants, and 79 (4%) had other or a combination of implants. 3-month outcome data were available for 2081 (99%) patients. Of these patients, 182 (9%, 95% CI 8–10) experienced implant loss, 372 (18%, 16–20) required re-admission to hospital, and 370 (18%, 16–20) required return to theatre for complications within 3 months of their initial surgery. 522 (25%, 95% CI 23–27) patients required treatment for an infection. The rates of all of these complications are higher than those in the National Quality Standards (&lt;5% for re-operation, re-admission, and implant loss, and &lt;10% for infection).</p> <p><strong>Interpretation</strong> Complications after immediate implant-based breast reconstruction are higher than recommended by national standards. A randomised clinical trial is needed to establish the optimal approach to immediate implant-based breast reconstruction.</p>
first_indexed 2024-03-07T01:13:44Z
format Journal article
id oxford-uuid:8ded6bb3-3a4c-406e-a8d3-d43ca532f6ac
institution University of Oxford
last_indexed 2024-03-07T01:13:44Z
publishDate 2019
publisher Elsevier
record_format dspace
spelling oxford-uuid:8ded6bb3-3a4c-406e-a8d3-d43ca532f6ac2022-03-26T22:54:21ZShort-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:8ded6bb3-3a4c-406e-a8d3-d43ca532f6acSymplectic Elements at OxfordElsevier2019Potter, SConroy, EJCutress, RIWilliamson, PRWhisker, LThrush, SSkillman, JBarnes, NLPMylvaganam, STeasdale, EJain, AGardiner, MBlazeby, JMHolcombe, C<p><strong>Background</strong> Use of biological or synthetic mesh might improve outcomes of immediate implant-based breast reconstruction—breast reconstruction with implants or expanders at the time of mastectomy—but there is a lack of high-quality evidence to support the safety or effectiveness of the technique. We aimed to establish the short-term safety of immediate implant-based breast reconstruction performed with and without mesh, to inform the feasibility of undertaking a future randomised clinical trial comparing different breast reconstruction techniques.</p> <p><strong>Methods</strong> In this prospective, multicentre cohort study, we consecutively recruited women aged 16 years or older who had any type of immediate implant-based breast reconstruction for malignancy or risk reduction, with any technique, at 81 participating breast and plastic surgical units in the UK. Data about patient demographics and operative, oncological, and complication details were collected before and after surgery. Outcomes of interest were implant loss (defined as unplanned removal of the expander or implant), infection requiring treatment with antibiotics or surgery, unplanned return to theatre, and unplanned re-admission to hospital for complications of reconstructive surgery, up to 3 months after reconstruction and assessed by clinical review or patient self-report. Follow-up is complete. The study is registered with the ISRCTN Registry, number ISRCTN37664281.</p> <p><strong>Findings</strong> Between Feb 1, 2014, and June 30, 2016, 2108 patients had 2655 mastectomies with immediate implant-based breast reconstruction at 81 units across the UK. 1650 (78%) patients had planned single-stage reconstructions (including 12 patients who had a different technique per breast). 1376 (65%) patients had reconstruction with biological (1133 [54%]) or synthetic (243 [12%]) mesh, 181 (9%) had non-mesh submuscular or subfascial implants, 440 (21%) had dermal sling implants, 42 (2%) had pre-pectoral implants, and 79 (4%) had other or a combination of implants. 3-month outcome data were available for 2081 (99%) patients. Of these patients, 182 (9%, 95% CI 8–10) experienced implant loss, 372 (18%, 16–20) required re-admission to hospital, and 370 (18%, 16–20) required return to theatre for complications within 3 months of their initial surgery. 522 (25%, 95% CI 23–27) patients required treatment for an infection. The rates of all of these complications are higher than those in the National Quality Standards (&lt;5% for re-operation, re-admission, and implant loss, and &lt;10% for infection).</p> <p><strong>Interpretation</strong> Complications after immediate implant-based breast reconstruction are higher than recommended by national standards. A randomised clinical trial is needed to establish the optimal approach to immediate implant-based breast reconstruction.</p>
spellingShingle Potter, S
Conroy, EJ
Cutress, RI
Williamson, PR
Whisker, L
Thrush, S
Skillman, J
Barnes, NLP
Mylvaganam, S
Teasdale, E
Jain, A
Gardiner, M
Blazeby, JM
Holcombe, C
Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study
title Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study
title_full Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study
title_fullStr Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study
title_full_unstemmed Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study
title_short Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study
title_sort short term safety outcomes of mastectomy and immediate implant based breast reconstruction with and without mesh ibra a multicentre prospective cohort study
work_keys_str_mv AT potters shorttermsafetyoutcomesofmastectomyandimmediateimplantbasedbreastreconstructionwithandwithoutmeshibraamulticentreprospectivecohortstudy
AT conroyej shorttermsafetyoutcomesofmastectomyandimmediateimplantbasedbreastreconstructionwithandwithoutmeshibraamulticentreprospectivecohortstudy
AT cutressri shorttermsafetyoutcomesofmastectomyandimmediateimplantbasedbreastreconstructionwithandwithoutmeshibraamulticentreprospectivecohortstudy
AT williamsonpr shorttermsafetyoutcomesofmastectomyandimmediateimplantbasedbreastreconstructionwithandwithoutmeshibraamulticentreprospectivecohortstudy
AT whiskerl shorttermsafetyoutcomesofmastectomyandimmediateimplantbasedbreastreconstructionwithandwithoutmeshibraamulticentreprospectivecohortstudy
AT thrushs shorttermsafetyoutcomesofmastectomyandimmediateimplantbasedbreastreconstructionwithandwithoutmeshibraamulticentreprospectivecohortstudy
AT skillmanj shorttermsafetyoutcomesofmastectomyandimmediateimplantbasedbreastreconstructionwithandwithoutmeshibraamulticentreprospectivecohortstudy
AT barnesnlp shorttermsafetyoutcomesofmastectomyandimmediateimplantbasedbreastreconstructionwithandwithoutmeshibraamulticentreprospectivecohortstudy
AT mylvaganams shorttermsafetyoutcomesofmastectomyandimmediateimplantbasedbreastreconstructionwithandwithoutmeshibraamulticentreprospectivecohortstudy
AT teasdalee shorttermsafetyoutcomesofmastectomyandimmediateimplantbasedbreastreconstructionwithandwithoutmeshibraamulticentreprospectivecohortstudy
AT jaina shorttermsafetyoutcomesofmastectomyandimmediateimplantbasedbreastreconstructionwithandwithoutmeshibraamulticentreprospectivecohortstudy
AT gardinerm shorttermsafetyoutcomesofmastectomyandimmediateimplantbasedbreastreconstructionwithandwithoutmeshibraamulticentreprospectivecohortstudy
AT blazebyjm shorttermsafetyoutcomesofmastectomyandimmediateimplantbasedbreastreconstructionwithandwithoutmeshibraamulticentreprospectivecohortstudy
AT holcombec shorttermsafetyoutcomesofmastectomyandimmediateimplantbasedbreastreconstructionwithandwithoutmeshibraamulticentreprospectivecohortstudy